Altıntaş, Y.E.; Kınıkoğlu, O.; Işık, D.; Güneş, T.K.; Özkerim, U.; Basoglu, T.; Sürmeli, H.; Odabaş, H.; Turan, N.
Very Favorable vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment. Cancers 2025, 17, 1076.
https://doi.org/10.3390/cancers17071076
AMA Style
Altıntaş YE, Kınıkoğlu O, Işık D, Güneş TK, Özkerim U, Basoglu T, Sürmeli H, Odabaş H, Turan N.
Very Favorable vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment. Cancers. 2025; 17(7):1076.
https://doi.org/10.3390/cancers17071076
Chicago/Turabian Style
Altıntaş, Yunus Emre, Oğuzcan Kınıkoğlu, Deniz Işık, Tuğçe Kübra Güneş, Uğur Özkerim, Tuğba Basoglu, Heves Sürmeli, Hatice Odabaş, and Nedim Turan.
2025. "Very Favorable vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment" Cancers 17, no. 7: 1076.
https://doi.org/10.3390/cancers17071076
APA Style
Altıntaş, Y. E., Kınıkoğlu, O., Işık, D., Güneş, T. K., Özkerim, U., Basoglu, T., Sürmeli, H., Odabaş, H., & Turan, N.
(2025). Very Favorable vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment. Cancers, 17(7), 1076.
https://doi.org/10.3390/cancers17071076
